Evidence map›Paper›PMID 41969753›Full record

ArticleOpen forum infectious diseases2026

Impact of Methicillin-Resistant

Tristan T Timbrook, Zijie Zhang, Tamara Krekel

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tristan T TimbrookDepartment of Pharmacy, Barnes-Jewish Hospital, Saint Louis, Missouri, USA.ORCID https://orcid.org/0000-0002-4542-6203
Zijie ZhangDepartment of Pharmacotherapy, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, North Carolina, USA.ORCID https://orcid.org/0000-0002-2075-7129
Tamara KrekelDepartment of Pharmacy, Barnes-Jewish Hospital, Saint Louis, Missouri, USA.ORCID https://orcid.org/0009-0000-2243-0798

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methicillin-resistant Methods: We searched PubMed and EMBASE through 29 June 2024 for studies evaluating MRSA nasal screening in adult inpatients with LRTIs. The primary outcome was duration of MRSA therapy. Secondary outcomes included frequency of vancomycin trough monitoring, hospital length of stay, incidence of acute kidney injury (AKI), in-hospital mortality, and 30-day readmission. We performed frequentist and Bayesian meta-analyses. Results: Fifteen studies (2872 patients) were included. Pharmacist-driven protocols (PDP) with PCR versus standard of care significantly reduced MRSA therapy duration (mean difference -1.34 days, 95% CI -1.59 to -1.08; Conclusions: Methicillin-resistant

Indexed as

antibiotic durationantimicrobial stewardshiplower respiratory infectionmeta-analysis

Identifiers

PMID41969753
PMCPMC13069566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.